Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7569612 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
US7741374 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
US7741373 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
US7915247 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) |
Market Authorisation Date: 14 August, 2009
Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet in patients with mixed dyslipidemia; Adjunctive therapy to diet in patients with elevated cholesterol and/or lip...
Dosage: TABLET;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic